Ascendis Pharma A (ASND) Interest Coverage Ratio (2014 - 2026)
Ascendis Pharma A's (ASND) quarterly Interest Coverage Ratio came in at 0.37 in Q1 2026, down 84.15% year-on-year from 2.33 in Q1 2025, and up 331.1% quarter-over-quarter from 0.16 in Q4 2025.
Ascendis Pharma A (ASND) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Ascendis Pharma A has disclosed Interest Coverage Ratio across 13 years of filings, most recently posting 0.37 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 0.37, down 84.15% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.19 (up 100.0% YoY), and the FY2025 annual result was 0.66, up 76.34% from the prior year.
- Interest Coverage Ratio came in at 0.37 for Q1 2026 at Ascendis Pharma A, up from 0.16 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 478.53 in Q4 2022 to a low of 29461538.46 in Q4 2024.
- The 5-year median for Interest Coverage Ratio is 1.6 (2025), against an average of 1733008.28.
- Across the five-year window, Interest Coverage Ratio plunged 5172869859.87% in 2024 and jumped 465.34% in 2025, its largest moves.
- Ascendis Pharma A's Interest Coverage Ratio stood at 478.53 in 2022, then tumbled by 100.12% to 0.57 in 2023, then slumped by 5172869859.87% to 29461538.46 in 2024, then jumped by 100.0% to 0.16 in 2025, then jumped by 331.1% to 0.37 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.37 (Q1 2026), 0.16 (Q4 2025), and 0.16 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Ascendis Pharma A | 2.75 Bn | 2.08 Bn | 268.20 Mn | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -1.60 |
| Mar 31, 2025 | 2.33 |
| Dec 31, 2024 | -29.46 Mn |
| Sep 30, 2024 | 3.82 |
| Jun 30, 2024 | -6.79 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -0.57 |
| Sep 30, 2023 | -5.48 |
| Jun 30, 2023 | -15.09 |
| Mar 31, 2023 | -14.60 |
| Dec 31, 2022 | 478.53 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -15.04 |
| Mar 31, 2022 | -23.71 |
| Dec 31, 2021 | 287.93 |
| Sep 30, 2021 | -110.53 |
| Jun 30, 2021 | -9.69 |